These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 18769000)

  • 1. Physical and chemical stability of palonosetron hydrochloride with five common parenteral drugs during simulated Y-site administration.
    Kupie TC; Trusley C; Ben M; Trissel LA
    Am J Health Syst Pharm; 2008 Sep; 65(18):1735-59. PubMed ID: 18769000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical and chemical stability of palonosetron hydrochloride with five opiate agonists during simulated Y-site administration.
    Trissel LA; Trusley C; Ben M; Kupiec TC
    Am J Health Syst Pharm; 2007 Jun; 64(11):1209-13. PubMed ID: 17519464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compatibility of palonosetron with cyclophosphamide and with ifosfamide during simulated Y-site administration.
    Xu QA; Trissel LA
    Am J Health Syst Pharm; 2005 Oct; 62(19):1998-2000. PubMed ID: 16174835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical and chemical stability of palonosetron HCl in 4 infusion solutions.
    Trissel LA; Xu QA
    Ann Pharmacother; 2004 Oct; 38(10):1608-11. PubMed ID: 15328393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride.
    Wu G; Yeung S; Chen F
    Int J Pharm Compd; 2017; 21(1):76-82. PubMed ID: 28346200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compatibility of tirofiban HCl with dopamine HCl, famotidine, sodium heparin, lidocaine HCl and potassium chloride during simulated Y-site administration.
    Bergquist PA; Hunke WA; Reed RA; Manas D; Forsyth RJ; Kenney RR; Cook J; Holahan M
    J Clin Pharm Ther; 1999 Apr; 24(2):125-32. PubMed ID: 10380064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection.
    Wu G; Powers D; Yeung S; Chen F
    Int J Pharm Compd; 2018; 22(1):76-85. PubMed ID: 29385388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palonosetron HCl compatibility and stability with doxorubicin HCl and epirubicin HCl during simulated Y-site administration.
    Trissel LA; Zhang Y
    Ann Pharmacother; 2005 Feb; 39(2):280-3. PubMed ID: 15613463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical and chemical stability of palonosetron hydrochloride with Fluorouracil and with gemcitabine hydrochloride during simulated y-site administration.
    Trissel LA; Zhang Y
    Int J Pharm Compd; 2005; 9(4):320-2. PubMed ID: 23925056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical and chemical stability of palonosetron with metoclopramide and promethazine during simulated y-site administration.
    Trusley C; Ben M; Kupiec TC; Trissel LA
    Int J Pharm Compd; 2007; 11(1):82-5. PubMed ID: 23974489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical and chemical stability of palonosetron hydrochloride with dacarbazine and with methylprednisolone sodium succinate during simulated y-site administration.
    Trissel LA; Zhang Y; Xu QA
    Int J Pharm Compd; 2006; 10(3):234-6. PubMed ID: 23974237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compatibility and stability of palonosetron hydrochloride with gentamicin, metronidazole, or vancomycin during simulated y-site administration.
    Kupiec TC; Ben M; Trusley C; Trissel LA
    Int J Pharm Compd; 2008; 12(2):170-3. PubMed ID: 23969611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical and chemical stability of palonosetron hydrochloride with Lorazepam and midazolam hydrochloride during simulated y-site administration.
    Trissel LA; Xu QA
    Int J Pharm Compd; 2005; 9(3):235-7. PubMed ID: 23924982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compatibility and stability of palonosetron hydrochloride with four neruomuscular blocking agents during simulated y-site administration.
    Trusley C; Ben M; Kupiec TC; Trissel LA
    Int J Pharm Compd; 2008; 12(2):156-60. PubMed ID: 23969608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical and chemical stability of palonosetron hydrochloride with topotecan hydrochloride and irinotecan hydrochloride during simulated y-site administration.
    Trissel LA; Xu QA
    Int J Pharm Compd; 2005; 9(3):238-41. PubMed ID: 23924983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical and chemical stability of palonosetron hydrochloride with glycopyrrolate and neostigmine during simulated y-site administration.
    Ben M; Trusley C; Kupiec TC; Trissel LA
    Int J Pharm Compd; 2008; 12(4):368-71. PubMed ID: 23969774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palonosetron hydrochloride compatiblity and stability with three B-lactam anitbiotic during simulated y-site adminstration.
    Ben M; Trusley C; Kupiec TC; Trissel LA
    Int J Pharm Compd; 2007; 11(6):520-4. PubMed ID: 23994813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration.
    Ben M; Kupiec TC; Trusley C; Trissel LA
    Int J Pharm Compd; 2008; 12(5):460-2. PubMed ID: 23969872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compatibility and stability of aloxi (palonosetron hydrochloride) admixed with dexamethasone sodium phosphate.
    Trissel LA; Zhang Y
    Int J Pharm Compd; 2004; 8(5):398-403. PubMed ID: 23924770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of palonosetron hydrochloride with paclitaxel and docetaxel during simulated Y-site administration.
    Xu QA; Trissel LA
    Am J Health Syst Pharm; 2004 Aug; 61(15):1596-8. PubMed ID: 15372835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.